Novartis Institutes for BioMedical Research, Inc. 5
5 · Intellia Therapeutics, Inc. · Filed Feb 14, 2019
Insider Transaction Report
Form 5
Transactions
- Other
Common Stock
2018-05-16+25,074→ 4,302,147 total - Other
Common Stock
2018-06-18+25,074→ 4,327,221 total - Other
Common Stock
2018-07-16+25,074→ 4,352,295 total
Footnotes (2)
- [F1]Pro rata distribution from Atlas Venture Fund IX, L.P., of which Novartis Institutes for BioMedical Research, Inc. ("NIBRI") is a limited partner.
- [F2]The shares are held directly by NIBRI. NIBRI is an indirect wholly-owned subsidiary of Novartis AG.